Aceto sees 24.1% rise in Q1 net sales
Aceto has posted a net income of $2.8m for the first quarter 2010, or $0.11 per diluted share, compared to $1m, or $0.04 per diluted share, for the
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.